tiprankstipranks
Kyowa Kirin Co Ltd (KYKOF)
OTHER OTC:KYKOF

Kyowa Kirin Co (KYKOF) Stock Price & Analysis

10 Followers

KYKOF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$15.10 - $20.31
Previous Close$16.47
Volume2.00K
Average Volume (3M)2.61K
Market Cap
$8.85B
Enterprise Value$6.69B
Total Cash (Recent Filing)¥339.72B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)15.5
Beta0.45
Aug 01, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.38%
Share Statistics
EPS (TTM)1.06
Shares Outstanding540,000,000
10 Day Avg. Volume130
30 Day Avg. Volume2,612
Standard Deviation0.08
R-Squared0.01
Alpha-0.00060
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

KYKOF FAQ

What was Kyowa Kirin Co Ltd’s price range in the past 12 months?
Kyowa Kirin Co Ltd lowest stock price was $15.10 and its highest was $20.31 in the past 12 months.
    What is Kyowa Kirin Co Ltd’s market cap?
    Currently, no data Available
    When is Kyowa Kirin Co Ltd’s upcoming earnings report date?
    Kyowa Kirin Co Ltd’s upcoming earnings report date is Aug 01, 2024 which is in 62 days.
      How were Kyowa Kirin Co Ltd’s earnings last quarter?
      Kyowa Kirin Co Ltd released its earnings results on May 07, 2024. The company reported $0.184 earnings per share for the quarter, beating the consensus estimate of N/A by $0.184.
        Is Kyowa Kirin Co Ltd overvalued?
        According to Wall Street analysts Kyowa Kirin Co Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Kyowa Kirin Co Ltd pay dividends?
          Kyowa Kirin Co Ltd does not currently pay dividends.
          What is Kyowa Kirin Co Ltd’s EPS estimate?
          Kyowa Kirin Co Ltd’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Kyowa Kirin Co Ltd have?
          Kyowa Kirin Co Ltd has 540,000,000 shares outstanding.
            What happened to Kyowa Kirin Co Ltd’s price movement after its last earnings report?
            Kyowa Kirin Co Ltd reported an EPS of $0.184 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.115%.
              Which hedge fund is a major shareholder of Kyowa Kirin Co Ltd?
              Currently, no hedge funds are holding shares in KYKOF
              ---

              Kyowa Kirin Co Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -13.31%
              12-Months-Change

              Fundamentals

              Return on Equity
              10.07%
              Trailing 12-Months
              Asset Growth
              0.71%
              Trailing 12-Months

              Company Description

              Kyowa Kirin Co Ltd

              Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It operates through the Pharmaceuticals and Bio-Chemicals segments. The Pharmaceuticals segment deals with the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension. The Bio-Chemicals segment produces and sells medical and industrial raw materials such as amino acids, nucleic acid-related compounds, and healthcare products. The company was founded by Benzaburo Kato on July 1, 1949 and is headquartered in Tokyo, Japan.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Takeda Pharmaceutical Company
              Bristol-Myers Squibb
              AstraZeneca
              Sanofi
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis